substance p, sar(9)-met(o2)(11)- has been researched along with pirenzepine in 5 studies
| Studies (substance p, sar(9)-met(o2)(11)-) | Trials (substance p, sar(9)-met(o2)(11)-) | Recent Studies (post-2010) (substance p, sar(9)-met(o2)(11)-) | Studies (pirenzepine) | Trials (pirenzepine) | Recent Studies (post-2010) (pirenzepine) |
|---|---|---|---|---|---|
| 151 | 0 | 6 | 3,812 | 587 | 140 |
| Protein | Taxonomy | substance p, sar(9)-met(o2)(11)- (IC50) | pirenzepine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.6891 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.5856 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.6134 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.6222 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.6227 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.6227 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.3406 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.6281 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0291 | |
| Muscarinic acetylcholine receptor M1 | Mus musculus (house mouse) | 0.75 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.9556 | |
| Muscarinic acetylcholine receptor M4 | Mus musculus (house mouse) | 0.75 | |
| Muscarinic acetylcholine receptor M5 | Mus musculus (house mouse) | 0.75 | |
| Muscarinic acetylcholine receptor M3 | Mus musculus (house mouse) | 0.75 | |
| Muscarinic acetylcholine receptor M2 | Mus musculus (house mouse) | 0.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
5 other study(ies) available for substance p, sar(9)-met(o2)(11)- and pirenzepine
| Article | Year |
|---|---|
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |